Médecins Sans Frontières and Epicentre

New Capabilities

Running the BRAVO study and pressing for wider access to Ebola vaccines

Congo's frontline health workers are still receiving the only Ebola vaccine available at scale, though it was designed for a different virus. The BRAVO study, which began September 19, is following 20,000 health workers in Ituri and North Kivu to see whether Ervebo protects them against Bundibugyo.

Updated Yesterday